Cryoablation used first line for paroxysmal atrial fibrillation (AF) is associated with reduced recurrence compared with pharmacotherapy, according to two North American trials.

Although ablation is recommended in international guidelines for treatment after antiarrhythmic drugs fail, its usefulness first line has been uncertain, according to the authors of both studies, which were published simultaneously in the New England Journal of Medicine.